Life Sciences Investor Survey 2019

Each year, Kempen performs a life sciences investor survey to gauge current investor sentiment within the life sciences industry. The most interesting results and trends from the 10th edition of the investor survey carried out this year are shown below.

life sciences investor survey 2019

 
Interested in receiving the full results of this year’s life sciences investor survey? Please contact us via the form below.

Unique position

As one of the few focused merchant banks in Europe, Kempen is uniquely positioned as a specialist in the life sciences and healthcare markets. We provide European companies access to a global network of specialist and generalist investors. The team has successfully executed over 110 life sciences transactions since its inception in 2005.

Want to know more?

Leave your company email address and we will contact you 

Please fill in a first name
Please fill in a last name
Please fill in your company name
Please fill in your phone number
This does not seem to be a valid email address
The information above is correct
Why do we store your information?

Kempen will use your name, telephone number and/or e-mail to respond to your request or subscription.

More information can be found in our Privacy Statement Merchant Banking and Privacy Statement for Asset Management.

* Upon sending this you approve that we save your information

Submitting your form

We have received your form

And we will get back to you soon.

Something went wrong

Please check your form for errors or try again later.
Disclaimer Kempen Privacy statement Kempen Disclaimer Kempen & Co Privacy statement Kempen & Co Statement under the UK Modern Slavery Act Cookie statement & settings
Kempen & Co is a trade name of Van Lanschot Kempen Wealth Management NV. Both Van Lanschot Kempen Wealth Management NV and Kempen Capital Management NV are part of Van Lanschot Kempen NV